Endovascular aneurysm repair devices market to reach $3.78B by 2030

The Business Research Company says the endovascular aneurysm repair devices market is set to rise from $2.62 billion in 2025 to $3.78 billion by 2030 as demand grows for minimally invasive vascular surgery and next-generation stent-grafts. North America was the largest regional market in 2025.

Why it matters: - Endovascular aneurysm repair devices support minimally invasive treatment for aortic aneurysms, which can reduce rupture risk and major complications. - The market’s growth signals broader adoption of less invasive vascular procedures and more advanced image-guided surgery tools.

What happened: - The Business Research Company released a market report on endovascular aneurysm repair devices on August 6, 2026. - The report projects the market will grow from $2.62 billion in 2025 to $2.83 billion in 2026. - The report forecasts the market will reach $3.78 billion by 2030. - The report says the market will grow at a 7.8% CAGR from 2025 to 2026 and at a 7.6% CAGR through 2030. - North America was the largest regional market in 2025.

The details: - EVAR devices treat aneurysms, especially in the aorta, through minimally invasive procedures. - The devices reinforce the weakened vessel wall and reroute blood flow away from the aneurysm. - Recent market growth has been supported by more aortic aneurysm cases, wider use of minimally invasive surgery, expansion of vascular surgery centers, advances in imaging-guided procedures and better catheter technologies. - Future growth drivers include broader use of next-generation stent-grafts, rising demand for customized vascular implants, stronger endovascular treatment capabilities, investment in hybrid operating rooms and a greater focus on long-term patient outcomes. - The report highlights emerging trends in minimally invasive repair techniques, advanced stent-graft technology, image-guided endovascular systems, customized device designs and procedural precision and safety. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis and updated graphics and tables. - The report offers a free sample and the full report through the company’s sample page and the full market report.

Between the lines: - The forecast points to steady but not explosive growth, with demand supported more by procedure mix and product upgrades than by a single breakthrough. - The emphasis on customized implants, hybrid operating rooms and image-guided systems suggests hospitals are pushing for more precise procedures and better outcomes. - A cited example from Intuitive Surgical showed 415 da Vinci systems deployed in the fourth quarter of 2023, up 12% from the prior year, underscoring broader momentum in minimally invasive surgery.

What's next: - The market is expected to keep expanding through 2030 as hospitals adopt newer stent-grafts and more advanced endovascular systems. - Manufacturers will likely compete on precision, safety, customization and integration with imaging and operating-room technology. - Regional growth outside North America will depend on access to vascular surgery infrastructure and adoption of minimally invasive care.